Identification of heterozygous carriers of lipid storage diseases. Current status and clinical applications.

@article{Brady1971IdentificationOH,
  title={Identification of heterozygous carriers of lipid storage diseases. Current status and clinical applications.},
  author={R. Brady and W. Johnson and B. Uhlendorf},
  journal={The American journal of medicine},
  year={1971},
  volume={51 4},
  pages={
          423-31
        }
}
Abstract Assay procedures are currently available for the detection of patients and carriers for all nine lipid storage diseases. In six of these conditions reliable determinations may be carried out with commercially available artificial substrates. In the remaining three diseases the use of radioactively labeled lipids is required for enzyme assays. Detection of heterozygotes for Niemann-Pick disease is reported for the first time. A potentially useful artificial substrate is proposed for the… Expand
The lipid storage diseases: new concepts and control.
  • R. Brady
  • Medicine
  • Annals of internal medicine
  • 1975
TLDR
Investigations of enzyme replacement therapy have shown great promise for the treatment of patients with Fabry's disease and those with the adult form of Gaucher's disease, but additional procedures must be developed for successful enzyme replacement in patients where the central nervous system is damaged by the accumulation of lipids. Expand
A practical chromogenic procedure for the detection of homozygotes and heterozygous carriers of Niemann-Pick disease.
TLDR
An analogue of sphingomyelin, 2-hexadecanoylamino-4-nitrophenylphosphorylcholine, was synthesized and is a reliable chromogenic reagent for the diagnosis of patients with Niemann-Pick disease and the detection of heterozygous carriers of the Nieman-Pick trait. Expand
Enzymological approaches to the lipidoses.
  • R. Brady
  • Medicine
  • Annals of clinical and laboratory science
  • 1977
TLDR
The development of facile chromogenic reagents for the diagnosis of patients with Niemann-Pick disease and Krabbe's disease is delineated and the novelty of these reagents and their application comprise the major aspect of this presentation. Expand
ELUCIDATION OF CLINICAL LYSOSOME DEFICIENCIES
TLDR
There are strong indications that enzyme replacement may become a useful therapeutic modality in the near future for certain lysosomal deficiency disorders. Expand
Present Status of Research in the Glycolipid Storage Diseases
TLDR
This chapter discusses some unresolved aspects that have arisen in the course of clinical and basic research investigations and recent technical improvements in glycolipid storage diseases. Expand
A microassay for Gaucher's disease.
We report a new assay for the detection of individuals heterozygous and homozygous for Gaucher's disease which requires relatively small samples of whole blood (0.3 ml), and which determinesExpand
Hereditary diseases--causes, cures, and problems.
Heritable catabolic and anabolic disorders of lipid metabolism.
  • R. Brady
  • Medicine
  • Metabolism: clinical and experimental
  • 1977
TLDR
The principal manifestations and metabolic defects in ten heritable disorders of lipid metabolism are discussed and enzyme replacement appears promising for patients with Fabry's disease and Gaucher's disease who do not have central nervous system damage. Expand
Enzymatic diagnosis of sphingolipidoses.
  • K. Suzuki
  • Biology, Medicine
  • Methods in enzymology
  • 1987
TLDR
The procedures described in this chapter are adequate for typical cases, but are likely to be too simplistic to cope with unusual enzymatic variants. Expand
The diagnosis of type A and type B Niemann Pick disease and detection of carriers using leukocytes and a chromogenic analogue of sphingomyelin.
TLDR
Investigations indicate that fresh leukocyte preparations may be employed with confidence for the diagnosis of patients with Type A and Type B Niemann-Pick disease and the detection of the respective heterozygotes using HNP as substrate. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 28 REFERENCES
Diagnosis of Gaucher's Disease and Niemann-Pick Disease with Small Samples of Venous Blood
TLDR
Enzymes which catalyze the hydrolysis of glucocerebroside and sphingomyelin have been demonstrated in preparations of washed human white blood cells and may be useful in the differential diagnosis of the sphingolipidoses. Expand
The diagnosis of the adult type of Gaucher's disease and its carrier state by demonstration of deficiency of beta-glucosidase activity in peripheral blood leukocytes.
  • E. Beutler, W. Kuhl
  • Chemistry, Medicine
  • The Journal of laboratory and clinical medicine
  • 1970
TLDR
Measurement of β-glucosidase activity at pH 4.0 makes it possible to distinguish patients with Gaucher's disease from heterozygote and from normal subjects, and makes possible identification of most heterozygotes. Expand
Fabry's Disease: Antenatal Detection
TLDR
The validity of Fabry's disease was substantiated by multiple enzyme and lipid analyses of tissue specimens obtained from the afflicted fetus, and it was included with other X-linked metabolic deficiency diseases that are amenable to precise genetic counseling, through carrier identification, and the monitoring of ensuing pregnancies. Expand
Enzymatic abnormality of the carrier state in metachromatic leukodystrophy
TLDR
The findings suggest that the heterozygous carrier state in metachromatic leukodystrophy could be predicted by the assay of arylsulfatase A in leukocytes and autosomal recessive mode of inheritance may be assumed. Expand
Genetic Inactivation of the α-Galactosidase Locus in Carriers of Fabry's Disease
TLDR
Evidence of genetic inactivation at the α-galactosidase locus makes possible the detection of carriers of Fabry's disease even when the enzymatic activity in their leukocytes and uncloned fibroblasts is within the range of controls. Expand
A pedigree study of metachromatic leukodystrophy
TLDR
The present study was based on the discovery of four patients with MLD in a large pedigree living in an isolated community in southwest Virginia, where extensive pairing of identical alleles has resulted in an increased incidence of this autosomal recessive disease. Expand
Demonstration of a deficiency of glucocerebroside-cleaving enzyme in Gaucher's disease.
TLDR
Evidence of a marked attenuation of glucocerebrosidecleaving activity in the spleen of patients with Gaucher's disease is presented. Expand
Deficiency of sphingomyelin-cleaving enzyme activity in tissue cultures derived from patients with Niemann-Pick disease.
Abstract The activity of the enzyme which catalyzes the hydrolysis of sphingomyelin has been assayed in tissue cultures derived from the skin and bone marrow of patients with different forms ofExpand
Intrauterine diagnosis and management of genetic defects.
TLDR
A classification of the clinical conditions exhibiting a genetic risk of sufficient magnitude to warrant intrauterine analysis is given and sex chromatin was shown to be correlated with karyotypic and phenotypic sex when limited to the midgestational stage. Expand
Sphingolipid metabolism in leukemic leukocytes.
TLDR
A marked increase in the activity of glucocerebroside-cleaving enzyme was observed in leukocyte preparations from the patients with acute and chronic myelogenous leukemia compared with the controls and patients with lymphocytic leukemia. Expand
...
1
2
3
...